Sunder Biomedical Tech. Co., Ltd.

4115 · TWO · Healthcare / Medical Instruments & Supplies

7.00TWD+0.03 (+0.43%)

Price History

Full chart

Market Stats

Previous Close6.97

Open6.97

Day Range6.65 – 7.00

52-Week Range6.53 – 12.10

Volume57.20K

Market Cap432.00M

P/E (TTM)72.00

Forward P/E0.00

EPS0.10

Dividend Yield0.00%

50-Day Avg7.49

200-Day Avg7.96

About

Sunder Biomedical Tech. Co., Ltd. manufactures and sells medical devices. The company offers endoscopy vision set, suction irrigation set, smoke filter, endo bag, blood line set for hemodialysis, A.V. fistula needle, I.V. administration, volume control I.V. administration, extension tube, surgical tubing set, PVC compounds for medical application, transducer protector, melt blown nonwoven fabric and mask, and protective goggles. It also provides components comprising caps for dialyzer adaptor and for female luer lock. The company was founded in 1998 and is headquartered in Yunlin, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOZhikai Hu
HeadquartersNo. 16, Chung-Chen Road, Yunlin, Taiwan, Taiwan
Websitehttps://www.sunder.com.tw

Leadership

Zhikai HuManager & Chairman
Yifeng GuoAccounting Supervisor

Financials

Income Statement

Currency: TWD	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	135.24M	143.63M	340.58M	429.14M	671.62M	691.19M	802.05M	841.88M	910.65M	1.14B	1.05B	770.19M	766.83M	753.45M
Growth (%)	-	+6.21%	+137.12%	+26.00%	+56.50%	+2.91%	+16.04%	+4.97%	+8.17%	+25.14%	-7.55%	-26.90%	-0.44%	-1.74%
Cost of Revenue	106.50M	139.36M	293.71M	370.56M	539.80M	608.94M	689.26M	702.45M	744.42M	938.83M	913.03M	692.28M	624.72M	650.97M
Gross Profit	28.74M	4.27M	46.86M	58.58M	131.82M	82.25M	112.80M	139.43M	166.23M	200.78M	140.52M	77.91M	142.11M	102.48M
Gross Margin	21.25%	2.97%	13.76%	13.65%	19.63%	11.90%	14.06%	16.56%	18.25%	17.62%	13.34%	10.12%	18.53%	13.60%
Operating Expense	32.17M	36.16M	45.02M	58.80M	75.96M	71.53M	95.99M	109.84M	103.76M	119.87M	124.72M	115.33M	118.02M	119.84M
Operating Income	-3.43M	-31.89M	1.84M	-218.00K	55.86M	10.72M	16.81M	29.59M	62.46M	80.91M	15.80M	-37.41M	24.09M	-17.36M
Operating Margin	-2.54%	-22.20%	0.54%	-0.05%	8.32%	1.55%	2.10%	3.51%	6.86%	7.10%	1.50%	-4.86%	3.14%	-2.30%
EBITDA	15.85M	-10.08M	38.38M	34.37M	97.84M	9.58M	71.55M	107.18M	154.82M	193.39M	127.49M	76.61M	125.61M	70.45M
EBITDA Margin	11.72%	-7.02%	11.27%	8.01%	14.57%	1.39%	8.92%	12.73%	17.00%	16.97%	12.10%	9.95%	16.38%	9.35%
Net Income	966.00K	-22.19M	4.15M	-11.41M	42.08M	-51.52M	4.70M	13.72M	52.58M	71.06M	13.32M	-33.16M	29.10M	-16.26M
Net Income Margin	0.71%	-15.45%	1.22%	-2.66%	6.27%	-7.45%	0.59%	1.63%	5.77%	6.24%	1.26%	-4.30%	3.79%	-2.16%
R&D	8.62M	9.90M	11.02M	4.36M	8.52M	10.27M	15.26M	26.26M	26.60M	25.63M	29.32M	29.43M	28.03M	30.00M
R&D as % of Total Revenue	6.38%	6.89%	3.24%	1.02%	1.27%	1.49%	1.90%	3.12%	2.92%	2.25%	2.78%	3.82%	3.66%	3.98%
Interest Expense	1.22M	2.75M	8.13M	11.11M	5.50M	6.22M	8.76M	11.36M	9.87M	9.19M	10.77M	12.51M	10.93M	9.43M
Interest Expense % of Total Revenue	0.90%	1.92%	2.39%	2.59%	0.82%	0.90%	1.09%	1.35%	1.08%	0.81%	1.02%	1.62%	1.43%	1.25%

Balance Sheet

Currency: TWD	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	-	-	-	1.51B	1.53B	1.43B	1.41B	1.32B	1.27B
Total Liabilities	-	-	-	-	757.79M	723.08M	635.02M	669.40M	540.04M	515.74M
Total Equity	-	-	-	-	755.45M	809.01M	790.45M	735.89M	777.43M	757.92M
Cash	-	-	-	-	115.92M	127.64M	133.62M	96.69M	130.44M	99.23M
Total Debt	-	-	-	-	599.78M	526.89M	476.55M	491.29M	401.46M	-
Net Debt	-	-	-	-	483.85M	399.25M	342.92M	394.60M	271.03M	284.19M

Cash Flow

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	104.75M	177.86M	104.42M	47.41M	108.13M	70.59M
Investing Cash Flow	-	-174.96M	-70.98M	-4.60M	-101.21M	9.25M	-
Financing Cash Flow	-	103.22M	-94.60M	-94.65M	30.52M	-97.41M	-
Capital Expenditure	0	139.14M	94.73M	73.85M	61.24M	98.15M	78.45M
Free Cash Flow	-	-34.39M	83.13M	30.58M	-13.83M	9.98M	-7.85M
Dividends Paid	-	-	18.00M	36.00M	18.00M	-	-
FCF to OCF	-	-32.83%	46.74%	29.28%	-29.17%	9.23%	-11.12%
Dividend Paid to FCF	-	-	21.65%	117.74%	-130.14%	-	-

Key Statistics & Ratios

Market Cap432.00M

Enterprise Value718.93M

Trailing P/E72.00

Forward P/E0.00

Price / Sales0.58

Price / Book0.56

EPS0.10

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding60.00M

Shares Float0

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%